International Journal of Homoeopathic Sciences

Osteoradionecrosis (ORN) is one of the most challenging among all adverse effects of radiotherapy. Overall incidence of osteoradionecrosis in head and neck ranges from 9 percent after dose of 70Gy to 2 percent following dose 60 Gy. Ischemia following radiation therapy is the principal causative factor but this disease is compounded by poor oral hygiene and poor dentition. In this retrospective study we tried to assess the efficacy of homeopathic drugs in management of osteoradionecrosis. The patients were referred to us by our radiation oncologist friend during the period of June 2022 to Dec 2022.

Aim of the study: To assess the role of homeopathic medicine in management of osteoradionecrosis.

Materials and Methods: Total 11 patients chosen for study.

?Patients treated from June 2022 to Dec 2022.

?All received a dose of 60 Gys.

?All have purulent discharge for more than 15 days and exposed bone.

?All patients having clinical, radiological and histopathological evidence of osteoradionecrosis.

?All patients fall outside this date range.

?Radiation defaulters’ patients.

?Patients who receive more or less doses than 60Gys.

?Patients associated with diabetes mellitus.

All subjects received drugs for 6 months. Patients were followed every month for 6 months.

?6 out of 11 patients have discharged subsided within a month and no further discharge.

?2 out of 11 had discharge subsided in a month but had more than two episodes of discharge.

?2 patients did not show any improvement and had to undergo surgical debridement.

?One patient lost in follow-up.

?4 patients have completely healed exposed bone.

?3 patients have partial healing,

?3 patients did not show any healing at all.

?60 percent of patients showed complete recovery following homeopathic treatment.

?20 percent of patients showed partial improvement.

?20 percent did not show any improvement.

Conclusion: In this retrospective analysis of limited patients we have seen excellent results following homeopathic medication. Which was further verified by a thankful gesture from a radiation oncologist friend who struggled a lot during treatment of osteoradionecrosis.